Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)

Stefania Aiello, Geoffrey Wells, Erica L. Stone, Hachemi Kadri, Rana Bazzi, David R. Bell, Malcolm F.G. Stevens, Charles S. Matthews, Tracey D. Bradshaw, Andrew D. Westwell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    New fluorinated 2-aryl-benzothiazoles, -benzoxazoles, and -chromen-4-ones have been synthesized and their activity against MCF-7 and MDA 468 breast cancer cell lines compared with the potent antitumor benzothiazole 5. Analogues such as 9a,b and 12a,d yielded submicromolar GI50 values in both cell lines; however, none of the new compounds approached 5 in terms of antitumor potency. For 5, binding to the aryl hydrocarbon receptor appeared to be necessary but not sufficient for growth inhibition.
    Original languageEnglish
    Pages (from-to)5135-5139
    JournalJournal of Medicinal Chemistry
    Volume51
    Issue number16
    Early online date31 Jul 2008
    DOIs
    Publication statusPublished - 28 Aug 2008

    Keywords

    • Cancer studies

    Fingerprint

    Dive into the research topics of 'Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)'. Together they form a unique fingerprint.

    Cite this